Walter Lau Wa To
Directeur/Membre du Conseil chez Birdie Biotech, Inc.
Profil
Walter Lau Wa To currently works at Oriengene Biotechnology Ltd., as Director, Birdie Biotech, Inc., as Director, Huapu Biotechnology Co., Ltd., as Director, Curegenix, Inc., as Director, and Start Shanghai Co., Ltd., as Director.
Dr. Wa To also formerly worked at Taiwan Liposome Co., Ltd., as Independent Director.
Dr. Wa To received his undergraduate degree from California Institute of Technology and doctorate degree from the University of California, Berkeley.
Postes actifs de Walter Lau Wa To
Sociétés | Poste | Début |
---|---|---|
Birdie Biotech, Inc.
Birdie Biotech, Inc. Medical SpecialtiesHealth Technology Birdie Biotech, Inc. develops novel targeted therapies for the treatment of cancer. The firm discovers, develops, and delivers innovative human therapeutics and break through a novel drug conjugation technology and to create new generation of targeted therapies. The company is headquartered in Beijing, China. | Directeur/Membre du Conseil | - |
Huapu Biotechnology Co., Ltd. | Directeur/Membre du Conseil | - |
Oriengene Biotechnology Ltd.
Oriengene Biotechnology Ltd. Pharmaceuticals: OtherHealth Technology Oriengene Biotechnology Ltd. develops drugs to treat cancer. | Directeur/Membre du Conseil | - |
Curegenix, Inc. | Directeur/Membre du Conseil | - |
Start Shanghai Co., Ltd. | Directeur/Membre du Conseil | - |
Anciens postes connus de Walter Lau Wa To
Sociétés | Poste | Fin |
---|---|---|
TAIWAN LIPOSOME COMPANY, LTD. | Directeur/Membre du Conseil | - |
Formation de Walter Lau Wa To
California Institute of Technology | Undergraduate Degree |
University of California, Berkeley | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
Entreprise privées | 6 |
---|---|
Taiwan Liposome Co., Ltd.
Taiwan Liposome Co., Ltd. Pharmaceuticals: MajorHealth Technology Taiwan Liposome Co., Ltd. engages in the research and development of lipid-based formulation drugs. Its products are used for pain management, eye disease treatment, and cancer treatment. The company was founded by Kee Lung Hong on November 10, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |
Oriengene Biotechnology Ltd.
Oriengene Biotechnology Ltd. Pharmaceuticals: OtherHealth Technology Oriengene Biotechnology Ltd. develops drugs to treat cancer. | Health Technology |
Birdie Biotech, Inc.
Birdie Biotech, Inc. Medical SpecialtiesHealth Technology Birdie Biotech, Inc. develops novel targeted therapies for the treatment of cancer. The firm discovers, develops, and delivers innovative human therapeutics and break through a novel drug conjugation technology and to create new generation of targeted therapies. The company is headquartered in Beijing, China. | Health Technology |
Huapu Biotechnology Co., Ltd. | |
Curegenix, Inc. | |
Start Shanghai Co., Ltd. |